Next Article in Journal
Recent Advances in Simulation Studies on the Protein Corona
Previous Article in Journal
Manipulation of Lipid Nanocapsules as an Efficient Intranasal Platform for Brain Deposition of Clozapine as an Antipsychotic Drug
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Zheng et al. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782

1
Drug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China
2
Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, China
3
Key Laboratory of New Drug Discovery Based on Classic Chinese Medicine Prescription, Beijing 100700, China
4
Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing 100700, China
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2024, 16(11), 1418; https://doi.org/10.3390/pharmaceutics16111418
Submission received: 30 October 2024 / Accepted: 30 October 2024 / Published: 5 November 2024
In the original publication [1], there was a mistake in Figure 4. In Figure 4C, S. aureus-BBR vs. MRSA-Control, S. aureus-TA vs. MRSA-BBR, and MRSA-TA vs. MRSA-BBR/TA MIX were repeated. All the pictures were combined using PPT software and then exported. Because the experimental steps for detecting the effects of the drugs on S. aureus and MRSA were exactly the same, and the experimental results of the above groups were similar, this led to an insertion error. However, the description of the results and the conclusion are correct. The corrected Figure 4 appears below. The order of the legend of Figure 4B,C is reversed, and the legend of Figure 4B should correspond to Figure 4C, and the legend of Figure 4C should correspond to Figure 4B. The correct legend appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Zheng, T.; Chen, H.; Wu, C.; Wang, J.; Cui, M.; Ye, H.; Feng, Y.; Li, Y.; Dong, Z. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782. [Google Scholar] [CrossRef] [PubMed]
Figure 4. Antibacterial mechanism of BBR-TA NPs. (A) Interaction of BBR, TA, BBR/TA MIX, and BBR-TA NPs with S. aureus and MRSA via SEM (scale bar = 200 nm). (B) The effect of BBR, TA, BBR/TA MIX, and BBR-TA NPs on the concentration of ATP in S. aureus cells and MRSA cells. (C) The effect of BBR, TA, BBR/TA MIX, and BBR-TA NPs on the membrane integrity of S. aureus and MRSA cells via LIVE /DEAD fixable dead cell stain assay (scale bar = 10 μm). (D) The effect of BBR, TA, BBR/TA MIX, and BBR-TA NPs on the cell cycle distribution of S. aureus and MRSA. *** p < 0.001; **** p < 0.0001.
Figure 4. Antibacterial mechanism of BBR-TA NPs. (A) Interaction of BBR, TA, BBR/TA MIX, and BBR-TA NPs with S. aureus and MRSA via SEM (scale bar = 200 nm). (B) The effect of BBR, TA, BBR/TA MIX, and BBR-TA NPs on the concentration of ATP in S. aureus cells and MRSA cells. (C) The effect of BBR, TA, BBR/TA MIX, and BBR-TA NPs on the membrane integrity of S. aureus and MRSA cells via LIVE /DEAD fixable dead cell stain assay (scale bar = 10 μm). (D) The effect of BBR, TA, BBR/TA MIX, and BBR-TA NPs on the cell cycle distribution of S. aureus and MRSA. *** p < 0.001; **** p < 0.0001.
Pharmaceutics 16 01418 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zheng, T.; Chen, H.; Wu, C.; Wang, J.; Cui, M.; Ye, H.; Feng, Y.; Li, Y.; Dong, Z. Correction: Zheng et al. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782. Pharmaceutics 2024, 16, 1418. https://doi.org/10.3390/pharmaceutics16111418

AMA Style

Zheng T, Chen H, Wu C, Wang J, Cui M, Ye H, Feng Y, Li Y, Dong Z. Correction: Zheng et al. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782. Pharmaceutics. 2024; 16(11):1418. https://doi.org/10.3390/pharmaceutics16111418

Chicago/Turabian Style

Zheng, Tingting, Huan Chen, Chenyang Wu, Jinrui Wang, Mengyao Cui, Hanyi Ye, Yifan Feng, Ying Li, and Zhengqi Dong. 2024. "Correction: Zheng et al. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782" Pharmaceutics 16, no. 11: 1418. https://doi.org/10.3390/pharmaceutics16111418

APA Style

Zheng, T., Chen, H., Wu, C., Wang, J., Cui, M., Ye, H., Feng, Y., Li, Y., & Dong, Z. (2024). Correction: Zheng et al. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782. Pharmaceutics, 16(11), 1418. https://doi.org/10.3390/pharmaceutics16111418

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop